Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Genocea Biosciences, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +4 vs. Q1 2021
- Shares held
- 33.9M
- +2.09M (+6.6%) vs. Q1 2021
- Total value
- $79.4M
- −$6.89M (−8.0%) vs. Q1 2021
- New holders
- 12
- 11 more added
- Sold out
- 8
- 7 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 900 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Artemis Wealth Advisors, LLC | 1,137 | $3.00K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 2,500 | $5.00K | 0.00% | +100+4.2% | Added |
| UBS Group AG | 3,834 | $9.00K | 0.00% | +3,834 | New |
| ACT Capital Management, LLC | 5,000 | $12.0K | 0.01% | +5,000 | New |
| Vectors Research Management, LLC | 5,000 | $12.0K | 0.00% | +5,000 | New |
| Pinz Capital Management, LP | 7,200 | $17.0K | 0.01% | +7,200 | New |
| Tower Research Capital LLC (TRC) | 8,574 | $20.0K | 0.00% | −328−3.7% | Reduced |
| Wells Fargo & Company | 9,532 | $22.0K | 0.00% | +20.0% | Added |
| ExodusPoint Capital Management, LP | 11,131 | $26.0K | 0.00% | −100−0.9% | Reduced |
| Capital Asset Advisory Services LLC | 11,766 | $28.0K | 0.00% | +11,766 | New |
| First Republic Investment Management, Inc. | 12,285 | $29.0K | 0.00% | +12,285 | New |
| Personal Capital Advisors Corp | 15,000 | $35.0K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 15,000 | $35.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 15,625 | $37.0K | 0.00% | +15,625 | New |
| Bank of New York Mellon Corp | 16,305 | $38.0K | 0.00% | −2,535−13.5% | Reduced |
| Morgan Stanley | 16,504 | $39.0K | 0.00% | +10,957+197.5% | Added |
| UBS Oconnor LLC | 19,170 | $45.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 19,675 | $46.0K | 0.00% | +14,760+300.3% | Added |
| State Street Corp | 19,684 | $46.0K | 0.00% | +19,684 | New |
| Commonwealth Equity Services, LLC | 20,705 | $48.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 23,095 | $54.0K | 0.00% | +23,095 | New |
| Northern Trust Corp | 39,882 | $93.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 43,643 | $102.0K | 0.01% | +43,643 | New |
| Bank of America Corp | 57,186 | $134.0K | 0.00% | −14,601−20.3% | Reduced |
| Diametric Capital, LP | 69,977 | $164.0K | 0.12% | +69,977 | New |
| Two Sigma Investments, LP | 154,447 | $361.0K | 0.00% | −234,562−60.3% | Reduced |
| BlackRock Inc. | 178,972 | $419.0K | 0.00% | +35,685+24.9% | Added |
| Geode Capital Management, LLC | 179,714 | $420.0K | 0.00% | +6,307+3.6% | Added |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $462.0K | 0.74% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 200,000 | $468.0K | 0.08% | +121,233+153.9% | Added |
| HighTower Advisors, LLC | 212,270 | $496.0K | 0.00% | +2,210+1.1% | Added |
| Two Sigma Advisers, LP | 248,477 | $581.0K | 0.00% | −156,000−38.6% | Reduced |
| Millennium Management LLC | 286,041 | $669.0K | 0.00% | +24,185+9.2% | Added |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $878.0K | 2.94% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,134,453 | $2.65M | 0.09% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,538,463 | $3.60M | 0.00% | −78,581−4.9% | Reduced |
| Citadel Advisors LLC | 1,872,236 | $4.38M | 0.00% | +41,450+2.3% | Added |
| Kingdon Capital Management, L.L.C. | 1,972,056 | $4.62M | 0.70% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,500,000 | $5.85M | 0.03% | +2,500,000 | New |
| Commodore Capital LP | 2,929,447 | $6.86M | 2.39% | +57,823+2.0% | Added |
| BVF Inc | 4,012,404 | $9.39M | 0.35% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 5,084,184 | $11.9M | 0.21% | 00.0% | Unchanged |
| NEA Management Company, LLC | 10,376,936 | $24.3M | 0.32% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −190,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −128,203−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −80,876−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −25,659−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,578−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −13,616−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,763−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |